These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 28710245

  • 21. The importance of differentiating ReoPro (c7E3 abciximab) induced thrombocytopenia from heparin-induced thrombocytopenia.
    Davidson SJ, Turner N, Clague JR, Oldershaw PJ, Burman JF.
    Thromb Haemost; 1999 Nov; 82(5):1560-1. PubMed ID: 10595660
    [No Abstract] [Full Text] [Related]

  • 22. Platelet receptor glycoprotein IIb/IIIa inhibition with eptifibatide in a patient with thrombocytopenia after treatment with abciximab.
    Coto H.
    J Invasive Cardiol; 2000 Oct; 12(10):528-31. PubMed ID: 11022214
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Abciximab readministration: results of the ReoPro Readministration Registry.
    Tcheng JE, Kereiakes DJ, Lincoff AM, George BS, Kleiman NS, Sane DC, Cines DB, Jordan RE, Mascelli MA, Langrall MA, Damaraju L, Schantz A, Effron MB, Braden GA.
    Circulation; 2001 Aug 21; 104(8):870-5. PubMed ID: 11514371
    [Abstract] [Full Text] [Related]

  • 26. Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab.
    Stiegler H, Fischer Y, Steiner S, Strauer BE, Reinauer H.
    Ann Hematol; 2000 Mar 21; 79(3):161-4. PubMed ID: 10803940
    [Abstract] [Full Text] [Related]

  • 27. Images in cardiovascular medicine. Abciximab-associated pseudothrombocytopenia.
    Holmes MB, Kabbani S, Watkins MW, Battle RW, Schneider DJ.
    Circulation; 2000 Feb 29; 101(8):938-9. PubMed ID: 10694535
    [No Abstract] [Full Text] [Related]

  • 28. Acute profound thrombocytopenia without bleeding complications after abciximab administration.
    Elmi F, Oza R, Mascarenhas DA.
    J Invasive Cardiol; 1999 May 29; 11(5):313-5. PubMed ID: 10745539
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Acute severe thrombocytopenia after treatment with ReoPro (abciximab).
    Butler R, Hubner PJ.
    Heart; 2000 Apr 29; 83(4):E5. PubMed ID: 10722557
    [Abstract] [Full Text] [Related]

  • 33. Abciximab: an updated review of its therapeutic use in patients with ischaemic heart disease undergoing percutaneous coronary revascularisation.
    Ibbotson T, McGavin JK, Goa KL.
    Drugs; 2003 Apr 29; 63(11):1121-63. PubMed ID: 12749745
    [Abstract] [Full Text] [Related]

  • 34. Uneventful use of tirofiban as an adjunct to coronary stenting in a patient with a history of abciximab-associated thrombocytopenia 10 months earlier.
    Desai M, Lucore CL.
    J Invasive Cardiol; 2000 Feb 29; 12(2):109-12. PubMed ID: 10731275
    [Abstract] [Full Text] [Related]

  • 35. Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Bhatt DL, Topol EJ.
    JAMA; 2000 Sep 27; 284(12):1549-58. PubMed ID: 11000650
    [Abstract] [Full Text] [Related]

  • 36. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
    Merlini PA, Rossi M, Menozzi A, Buratti S, Brennan DM, Moliterno DJ, Topol EJ, Ardissino D.
    Circulation; 2004 May 11; 109(18):2203-6. PubMed ID: 15117843
    [Abstract] [Full Text] [Related]

  • 37. Standard versus low-dose weight-adjusted heparin in patients treated with the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3 Fab) during percutaneous coronary revascularization. PROLOG Investigators.
    Lincoff AM, Tcheng JE, Califf RM, Bass T, Popma JJ, Teirstein PS, Kleiman NS, Hattel LJ, Anderson HV, Ferguson JJ, Cabot CF, Anderson KM, Berdan LG, Musco MH, Weisman HF, Topol EJ.
    Am J Cardiol; 1997 Feb 01; 79(3):286-91. PubMed ID: 9036746
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.